Author: abhishek

Peripheral

luminor

Post author By abhishek
Post date August 13, 2022

Luminor

Paclitaxel eluting PTA balloon dilatation catheter
The DCB you need

PRODUCT FEATURES

Easy navigation

Small profiles

Short deflation times and wide size range (0.014”, 0.018” and 0.035” guidewire compatibilities)

Coating technology matters Not all DCBs are the same

Has an ultrathin coating thanks to the nanodrop technology used to coat the balloons.
Ensures a durable coating due to its multilayer technology, with minimum drug loss during navigation.
Ensures a uniform artery treatment

CLINICAL SUPPORT

Luminor has demonstrated its safety and efficacy in long term follow-up and in different indications:

EffPac Trial

Multicenter, randomized and controlled trial, Luminor vs POBA. 90.1% fTLR at 3.5 years

TINTIN Trial

Prospective, multicenter trial, with Luminor and iVolution combined therapy in TASC C&D lesions. 89.4% fTLR at 2 years

MERLION Trial

Prospective, multicenter trial, with Luminor and Angiolite BTK as bailout stenting in BTK. 81.6% fTLR at 1 year

Other trials: BIBLIOS,LUMBRA,LUMIFOLLOW, SOL JAPAN, LUMINOR registry.

Coronary

Xperience pro

Xperience pro

Coronary balloon dilatation catheter
The balloon that crosses all lesions

PRODUCT FEATURES

Coronary

NC xperience

NC xperience

Coronary balloon dilatation catheter
For calcified lesions preparation

PRODUCT FEATURES

Coronary

Capturer

Capturer

Thrombus extraction catheter
A unique design for high aspiration

PRODUCT FEATURES

Outstanding navigation

Flexible
radiopaque markers
increases distal flexibility

Propietary
hydrophilic coating
Reduces friction with artery wall

Propietary
braiding technology
Very low kinking radius

High aspiration capacity

Extraction in all situations avoiding collapse thanks to its special tip design

Capturer offers big extraction areas and high aspiration capacity

Coronary

Architect

Architect

Coronary stent

PRODUCT FEATURES

Coronary

Navitian

Navitian

Coronary microcatheter Simplifying the complex

PRODUCT FEATURES

Coronary

Essential pro

Essential Pro

Paclitaxel eluting coronary balloon dilatation catheter
The novel reliable DCB

PRODUCT FEATURES

Optimal navigation

High pushability
Improved transition lumen

Improved visibility
Pt/Ir MRO

Excellent trackability
Hydrax plus

Coating technology matters Not all DCBs are the same

Has a ultrathin coating thanks to the nano drop technology used to coat the balloons.
Ensures a durable coating due to its multilayer technology.
Ensures a uniform artery treatment

CLINICAL SUPPORT

Essential pro has proven its safety and efficacy in the following clinical trials and registries

Small Vessels Registry

Observational, prospective and multicenter registry 4.2% TLF at 12 months

ISR Study

Observational, prospecive, multicenter and investigator-initiated study 51.4% In segment maximal area stenosis at 6 months

Coronary

Angiolite

Angiolite

Coronary sirolimus stent
The DES we trust

PRODUCT FEATURES

Excellent performance even in compromised situations

Left Main and bifurcation lesions: One of the highest overexpansion capacity for large vessels 6.00mm

75µm
Small vessels:
Adapted to the need of the arteries with thin struts

Diffuse lesions: new available lengths 44 & 49mm

Calcified lesions: excellent arterial support +40% vs competitors

High quality of healing

TransferWise, the iVascular proprietary technology that provides a homogenous drug elution that translates into lower rates of restenosis and inflammation score.
Our fluoro-acrylate polymer provides an early endothelialization and creates a thromboresistant layer. This mechanism suggest to reduce stent thrombosis.

CLINICAL SUPPORT

Angiolite has proven its safety and efficacy in the following clinical trials and registries

ANCHOR Study

Observational, prospective, multicenter study 86.3% Strut coverage at 3 months

ANGIOLITE Trial

Randomized, non-inferiority, observational, prospective, multicenter trial 0.04mm LLL at 6 months

RANGO Registry

Prospective, single arm, multicenter observational registry 3.4% TLF at 2 year